Topical Compositions for Treatment of Psoriasis
AssigneePrestigio Ltd.
InventorsDavid Merary, Iris Raveh
Life of this patent
Estimating the term…
Loading patent…
AssigneePrestigio Ltd.
InventorsDavid Merary, Iris Raveh
Estimating the term…
The present invention provides safe and effective topical compositions for the treatment of psoriasis and alleviation and prevention of frequent recurrence of psoriasis symptoms as well as treatment of seborrheic dermatitis. The compositions comprise therapeutically effective amounts of salicylic acid, zinc oxide, bisabolol, at least one pharmaceutically acceptable carrier selected from the group comprising white petrolatum, lanolin, propylene glycol, and combinations thereof, herbal oils selected from the group comprising Salvia Hispanica seed oil, evening primrose oil, grape seed oil, Nigella seed oil, Silybum Marianum oil, Prunus Amygdalus Dulcis (sweet almond) oil, borage oil, Lavendula Angustifolia (lavender) oil, Cannabis sativa seed oil and mixtures thereof and other pharmaceutically acceptable ingredients. Unlike many topical compositions for the treatment of these skin afflictions, the compositions of the instant invention do not contain steroids (like cortisone) or coal tar. They are hypoallergenic and essentially free of side-effects.
A topical composition for the treatment of psoriasis or alleviation of frequent recurrence of psoriasis symptoms or the treatment of seborrheic dermatitis, comprising therapeutically effective amounts of 2-4% w/w salicylic acid, 8-10% w/w zinc oxide, 10-15% w/w white petrolatum, 10-14% w/w lanolin, 4-6% w/w/grape seed oil, 4-6% w/w Calendula Officinalis flower oil, 4-6% w/w evening primrose oil, 2-4% w/w beeswax, 0.5-3% w/w Nigella seed oil, 1-3% w/w calamine, 0.5-3% Silybum Marianum seed oil, 0.5-2% w/w Vitamin A or its palmitate, 0.5-2% w/w Vitamin E or its acetate, 0.5-2% w/w borage oil, 0.5-2% w/w sweet almond oil, 0.5-2% w/w bisabolol, 0.1-0.3% w/w lavender oil, additional herbal oils selected from the group consisting of 0-7% w/w Salvia Hispanica seed oil, 0-5% w/w White Willow oil, 0-5% Linum Usitatissimum seed oil, 0-5% w/w Anthemis Nobilis flower oil, 0-6% w/w Cannabis Sativa seed oil and mixtures thereof and pharmaceutically acceptable ingredients selected from the group consisting of 0-3% w/w polysorbate 80, 0-2% w/w phenoxyethanol, 0-10% w/w corn starch, 0-3% w/w polyethylene-20-sorbitan tristearate, 0-16% w/w propylene glycol, 0-3% w/w cyclomethicone, 0-6% w/w elastomer blend, 0-12% w/w purified water and mixtures thereof.
Dependencies are inferred from the claim text.